Epididymal fat tissue
|
2 week |
Olfactory transduction |
Adrbk2 (4), Olfr513 (6), Olfr433 (15), Camk2g (28), Olfr1245 (29), Olfr1143 (36), Olfr996 (55), Olfr960 (57), Arrb2 (79) |
|
Wnt signaling pathway |
Camk2g (28), Rhoa (31), Wnt10a (95) |
|
Melanogenesis |
Camk2g (28), Adcy5 (80), Wnt10a (95) |
|
Chemokine signaling pathway |
Rhoa (31), Arrb2 (79), Adcy5 (80) |
|
Focal adhesion |
Rhoa (31), Lamc3 (44), Bcl2 (77) |
|
Pathways in cancer |
Rhoa (31), Bcl2 (77), Wnt10a (95) |
4 week |
Olfactory transduction |
Camk2g (17), Olfr513 (27), Olfr960 (31), Olfr1245 (43), Arrb2 (55) |
|
Pathways in cancer |
Gli2 (1), Lamc3 (9), Bcl2 (58), Fgf5 (65) |
|
MAPK signaling pathway |
Arrb2 (55), Fgf5 (65), Mapkapk5 (75) |
|
Purine metabolism |
Gucy2c (2), Nme7 (47), Cant1 (85) |
8 week |
Olfactory transduction |
Olfr536 (11), Olfr513 (31), Olfr654 (37), Camk2g (74), Olfr652 (99) |
|
Focal adhesion |
Flnc(16), Bcl2 (64), Col6a2 (83), Rhoa (86), Mylk (96), |
|
Regulation of actin cytoskeleton |
Fgf5 (26), Rhoa (86), Mylk (96) |
|
Pathways in cancer |
Fgf5 (26), Bcl2 (64), Rhoa (86) |
12 week |
Olfactory transduction |
Olfr16 (6), Camk2g (10), Olfr715 (24), Olfr1245 (32), Olfr536 (36), Olfr1143 (52) |
|
Neuroactive ligand-receptor interaction |
Pth2r (1), Agtrl1 (16), Vipr2 (27), P2rx6 (74) |
|
Focal adhesion |
Lamc3 (4), Bcl2 (75), Col6a2 (76), Rhoa (88) |
|
ECM-receptor interaction |
Lamc3 (4), Cd44 (59), Col6a2 (76) |
|
Pathways in cancer |
Lamc3 (4), Bcl2 (75), Rhoa (88) |